Cardiovascular Research

Choose native proteins that retain biologically relevant structure and post-translational modifications to advance cardiovascular science from discovery through clinical development.

From cardiometabolic pathways to vascular biology, Athens’ highly pure, highly active proteins allow you to interrogate molecular mechanisms, validate cardiovascular biomarkers, and develop robust diagnostics and therapeutics.

Explore our broad cardiovascular portfolio—spanning glycoproteins, immune mediators, coagulation and hemostasis markers, and more—or partner with us for custom solutions.

Experience the Athens Standard:

Immunogen-grade options (≥98% purity) for antibody workflows
Lot-specific CoAs with activity and purity data
95% same- or next-day shipping

Native activity. Trusted purity. Reliable results.

Our Cardiovascular Research Products in Action

Athens provides native human proteins that meet the demands of modern cardiovascular research, empowering teams to investigate physiological and pathophysiological processes, discover and validate biomarkers, develop diagnostics, and innovate therapeutics.

The Athens Advantage:

Broad cardiovascular research product portfolio, spanning coagulation, cardiometabolic, vascular, and immune biology
Native structure and activity, enabling target discovery and validation across diverse cardiovascular pathways
High purity and reproducibility, ensuring confidence in signal stability and reducing lot-to-lot variability
Consistent quality, form, fit, and function from mg to kg, simplifying revalidation as you scale
High yields and batch reservations from single or pooled donors, supporting long-term cardiovascular research and manufacturing workflows

Explore how researchers worldwide have used Athens products to power cardiovascular research:

Contois, et al. developed rapid ELISA assays to accurately measure Lipoprotein(a), an important cardiovascular risk factor¹
Mehta, et al. defined the role of hemopexin in atherosclerosis and vascular inflammation²
Chen, et al. characterized heme-induced neutrophil extracellular traps (NETs) in sickle cell disease³

Want a deeper look?

Explore peer-reviewed studies featuring our cardiovascular research products.

Browse All Citations

*1. Contois, et al. Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms. Clinica Chimica Acta 505, 2020, 119–124. https://doi.org/10.1016/j.cca.2020.02.030 / Sun Diagnostics, USA

*2. Mehta, et al. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function. Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1152-63. https://doi.org/10.1161/ATVBAHA.115.306991

*3. Chen, et al. Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood. 2014 Jun 12;123(24):3818-27. https://doi.org/10.1182/blood-2013-10-529982

Explore Other Products

In Vitro Diagnostics

Reagents with superior purity and activity for reliable, accurate, and sensitive diagnostic test development.

Pulmonary & Respiratory Disease

Native proteins for respiratory research and diagnostics, from pulmonary inflammation to lung function biomarkers.

Coagulation & Hemostasis Proteins

Plasminogen, plasmin, and antithrombin—proteins linking coagulation to tumor angiogenesis and metastasis.

Enzymes & Protease Inhibitors

Native enzymes and inhibitors, purified and QC-tested in-house for consistent activity and trusted results.

Antibodies & Immune Proteins

Pure native antibodies, immunoglobulins, and more for reliable IVD development and broad research use.

Explore All Products

Need something unique?

Set your own specs—buffer, purity, scale, and beyond—and get custom cardiovascular research products configured to your process requirements.

Get In Touch

Explore Custom Solutions

Cardiovascular Research